The Relationship Between Myostatin, Inflammatory Markers, and Sarcopenia in Patients With Chronic Kidney Disease.

Objective: To determine the prevalence of sarcopenia in patients with chronic kidney disease (CKD), investigate the relationship of the serum myostatin level with sarcopenia and inflammatory markers.Methods: The study was conducted with four patient groups: renal transplantation (TX), stage 3-5 non-...

Descripción completa

Detalles Bibliográficos
Publicado en:Journal of Renal Nutrition Vol. 32; no. 6; pp. 677 - 685
Autores principales: Yasar, Emre, Tek, Nilüfer Acar, Tekbudak, Merve Yasemin, Yurtdaş, Gamze, Gülbahar, Özlem, Uyar, Gizem Özata, Ural, Zeynep, Çelik, Özge Mengi, Erten, Yasemin
Formato: research Journal Article
Publicado: W B Saunders Nov 2022
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=160250229&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 160250229
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        10512276
        DOT
      jtl: Journal of Renal Nutrition
      issn: 10512276
      maglogo: N
    pubinfo:
      dt: Nov 2022
      vid: 32
      iid: 6
      pid: 1351
      pub: W B Saunders
      place: Philadelphia, Pennsylvania
    artinfo:
      ui:
        160250229
        160250229
        NLM35122995
        160250229
        10.1053/j.jrn.2022.01.011
        NLM35122995
        160250229
      ppf: 677
      ppct: 8
      formats:
      tig:
        atl: The Relationship Between Myostatin, Inflammatory Markers, and Sarcopenia in Patients With Chronic Kidney Disease.
      aug:
        au:
          Yasar, Emre
          Tek, Nilüfer Acar
          Tekbudak, Merve Yasemin
          Yurtdaş, Gamze
          Gülbahar, Özlem
          Uyar, Gizem Özata
          Ural, Zeynep
          Çelik, Özge Mengi
          Erten, Yasemin
        affil: Gazi University, Faculty of Medicine, Department of Nephrology, Ankara, Turkey
      sug:
        subj:
          Kidney Failure, Chronic Therapy
          Sarcopenia Diagnosis
          Renal Insufficiency, Chronic Therapy
          Grip Strength Physiology
          Female
          Intercellular Signaling Peptides and Proteins
          Muscle, Skeletal
          Hemodialysis
          Male
          Human
          Female
          Male
      ab: Objective: To determine the prevalence of sarcopenia in patients with chronic kidney disease (CKD), investigate the relationship of the serum myostatin level with sarcopenia and inflammatory markers.Methods: The study was conducted with four patient groups: renal transplantation (TX), stage 3-5 non-dialysis-dependent CKD (NDD-CKD), hemodialysis (HD), and peritoneal dialysis (PD). Laboratory parameters, serum myostatin, C-reactive protein, and interleukin-6 levels were studied. Body composition was estimated using a multifrequency bioimpedance analysis. Handgrip strength (HGS) was evaluated with a handgrip dynamometer. The HGS and appendicular skeletal muscle index measurements were used to determine sarcopenia presence.Results: The study included 130 patients (72 [55%] male patients). The patient distribution in groups was as follows: 37 in HD, 28 in PD, 37 in renal TX, and 28 in NDD-CKD. The highest level of myostatin was measured in the HD group, and the lowest in the TX group (P < .001). The HGS measurement in the PD group was significantly lower than that in the TX group (P = .025). The myostatin was negatively correlated with HGS, albumin, estimated glomerular filtration rate, and Kt/Vurea. However, myostatin had no correlation with inflammatory markers or appendicular skeletal muscle index. Sarcopenia was present in 37 (29%) patients: 15 (40%) in the HD group, nine (32%) in NDD-CKD, seven (25%) in PD, and six (16%) in TX. When the patients with and without sarcopenia were compared, only myostatin was higher in the former (P = .045). As a result of multivariate analysis, myostatin was the only independent factor which predicts sarcopenia (odds ratio: 1.002, 95% confidence interval: 1.001-1.005, P = .048).Conclusion: To prevent devastating events associated with sarcopenia in patients with CKD, renal transplantation seems to be the best treatment solution. For the early recognition of sarcopenia, the measurement of the serum myostatin level may be a promising diagnostic approach.
      pubtype: Academic Journal
      doctype:
        research
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N